Cognitive function may be a predictor of retinopathy progession in patients with type 2 diabetes. by Borio, L et al.
Cognitive function may be a predictor of retinopathy progession in patients with type 2 diabetes. 
Borio L, Salassa M, Baltatescu A, °Charrier L, °Cavallo F, Porta M and Trento M. 
 
Laboratory of Clinical Pedagogy, Departments of Medical Sciences   
°Public Health and Pediatric Science, University of Turin. 
 
 
Background 
Cognitive function,depression and anxiety may be associated with type 2 diabetes(T2DM) and its 
complications. In particular diabetic retinopathy (DR) is a complication that affects people with 
diabetes. 
Aim 
In an observational prospective study of a cohort of T2DM patients followed for 8 years,we monitored a 
number of clinical, psychological and cognitive variables to identify possible predictors of progression of 
DR. 
Patients and Methods 
Patients (n=498) with T2DM, of which 249 not treated by insulin (NIT) and 249 on insulin treatment (IT), 
were enrolled at baseline. The following variables were recorded: age, gender, diabetes duration, schooling, 
occupation, social status, smoking, self-monitoring of blood glucose, hypertension, menopausal status, 
fasting blood glucose, HbA1c, BMI, total and HDL cholesterol, triglyceride, retinopathy grading, presence of 
foot ulcers, depression and anxiety scores (Zung questionnaire) and cognitive function (Minimal Mental 
State Examination, MMSE). The same variables were collected again after 4 (JEI 37,79-85,2014)  and 8 
years. DR assessment was by grading of digital 45° photographs of the macular and nasal areas. Grading of 
the worst eye was considered.  
Results 
Out of 477 patients for whom fundus evaluation was available at baseline, 240 (160 IT and 80 NIT) had no 
DR, 110 (48 NIT and 62 IT) had mild non proliferative DR and 127 (24 NIT and 103 IT) had moderate or 
more severe DR. After 8 years, 357 patients were available for analysis, of whom 191 had remained with no 
or mild DR and 166 had developed moderate or more severe DR. Patients who had moderate or more severe 
DR at baseline were not included in the follow-up analysis. On multivariate analysis, being on insulin 
treatment (OR 1.90, 95%CI 1.02;3.55, p=0.043) and having mild vs no DR at baseline (OR 4.51, 2.44;8.31, 
p<0.0001) were associated with progression to moderate/more severe DR, whereas male gender (OR 0.49, 
0.26;0.92, p=0.028) and a higher MMSE score (indicative of better cognitive ability) (OR 0.90 per scoring 
point; 0.83;0.99, p=0.026) were protective. None of the other baseline variables was associated with 
progression of DR in this cohort. 
Conclusions 
Lower MMSE score may represent a novel risk factor for progression of DR, on top of other known 
determinants. Microangiopathy might develop at both brain and retinal level and manifest itself with changes 
in cognitive function and retinopathy. 
